CIO Insight: Drug Scientists Slow to Adopt Open Source
Sep 08, 2005, 19:00 (3 Talkback[s])
(Other stories by M.L. Baker)
Desktop-as-a-Service Designed for Any Cloud ? Nutanix Frame
"A surge in open-source technology offers many businesses a
potent combination of power and low cost, but the pharmaceutical
industry remains well behind the curve.
"That was the message at a session on data visualization and
integration at a semiannual meeting of the nation's chemists in
Washington last week..."